Are you Dr. Hagenkord?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 40 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 N 30th St
Omaha, NE 68131Phone+1 402-449-4630- Is this information wrong?
Summary
- Dr. Jill Hagenkord, MD is a board certified pathologist in Omaha, Nebraska. She is currently licensed to practice medicine in Nebraska, Utah, and California.
Education & Training
UPMC Medical EducationFellowship, Molecular Genetic Pathology, 2007 - 2008
University of Iowa Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 2002 - 2006
University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1999 - 2002
Stanford University School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2012 - 2025
UT State Medical License 2014 - 2022
NE State Medical License 2008 - 2014
IA State Medical License 2002 - 2012
PA State Medical License 2005 - 2008- American Board of Pathology Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 3 citationsStewardship of patient genomic data: A policy statement of the American College of Medical Genetics and Genomics (ACMG).Robert G Best, George Khushf, Sara Schonfeld Rabin-Havt, Ellen Wright Clayton, Theresa A Grebe, Jill Hagenkord, Scott Topper, Jaime Fivecoat, Margaret Chen, Wayne W Grody> ;Genetics in Medicine. 2022 Mar 1
- 13 citationsDesign and Reporting Considerations for Genetic Screening TestsJill M. Hagenkord, Birgit Funke, Emily Qian, Madhuri Hegde, Kevin B. Jacobs, Matthew J. Ferber, Matthew S. Lebo, Adam H. Buchanan, David P. Bick> ;The Journal of Molecular Diagnostics. 2020 May 1
- 16 citationsEvaluation for Genetic Disorders in the Absence of a Clinical Indication for Testing: Elective Genomic Testing.James T. Lu, Matthew J. Ferber, Jill M. Hagenkord, Elissa Levin, Sarah T. South, Hyunseok Kang, Kimberly A. Strong, David P. Bick> ;The Journal of Molecular Diagnostics. 2019 Jan 1
- Join now to see all
Press Mentions
MDisrupt Launches a Medical Diligence Service to Bring Scientific Rigor to Silicon ValleyAugust 25th, 2019
MDisrupt Launches the World’s First Medical Diligence CompanyAugust 21st, 2019
Morning Headlines 8/13/19August 12th, 2019- Join now to see all
